Russell Biotech Inc Doylestown, PA - 18901

Russell Biotech Inc is categorized under Commercial Biotechnical Research in Doylestown, PA and active since 2005.

Russell Biotech Inc was established in 2005, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Thomas Russell at the company’s single location by writing to 403 Lantern Drive, Doylestown, Pennsylvania PA 18901 or by phoning (215) 348-2988. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Russell Biotech Inc
Contact Person: Thomas Russell
Address: 403 Lantern Drive, Doylestown, Pennsylvania 18901
Phone Number: (215) 348-2988
Website Address: russellbiotech.com
Annual Revenue (USD): $50.000 to $99.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Russell Biotech Inc was started in 2005 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Thomas Russell for inquiries that concern Russell Biotech Inc by calling the company number (215) 348-2988, as your correspondence is most welcome. Additionally, the physical location of the single location of Russell Biotech Inc can be found at the coordinates 40.319459,-75.136981 as well as the street address 403 Lantern Drive in Doylestown, Pennsylvania 18901.

For its online presence, you may visit Russell Biotech Inc’s website at russellbiotech.com and engage with its social media outlets through on Twitter and on Facebook.